Patents by Inventor Diana CEPEDA

Diana CEPEDA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INTRAVITREAL DOSING FOR DELIVERY OF POLYNUCLEOTIDES TO RETINAL CONES
    Publication number: 20230062110
    Abstract: Provided is the intravitreal dosing of recombinant adeno-associated virus (rAAV)-based gene therapies for the treatment of color vision deficiencies such as Blue Cone Monochromacy (BCM) and Red-Green Color Blindness.
    Type: Application
    Filed: March 25, 2022
    Publication date: March 2, 2023
    Inventors: Claire GELFMAN, Diana CEPEDA, Ruslan GRISHANIN, Kristina BENDER, Pallavi SHARMA, Julio NIEVES
  • Variant AAV capsids for intravitreal delivery
    Patent number: 11510950
    Abstract: Provided are variant adeno-associated virus (AAV) capsid proteins and recombinant AAV virions having one or more variant AAV capsid proteins. Also provided are compositions and methods for the use of the recombinant AAV virions, such as for the treatment or prophylaxis of a disease or disorder.
    Type: Grant
    Filed: April 24, 2020
    Date of Patent: November 29, 2022
    Assignee: ADVERUM BIOTECHNOLOGIES, INC.
    Inventors: Annahita Keravala, Diana Cepeda, Mehdi Gasmi
  • VARIANT AAV CAPSIDS FOR INTRAVITREAL DELIVERY
    Publication number: 20200338146
    Abstract: Provided are variant adeno-associated virus (AAV) capsid proteins and recombinant AAV virions having one or more variant AAV capsid proteins. Also provided are compositions and methods for the use of the recombinant AAV virions, such as for the treatment or prophylaxis of a disease or disorder.
    Type: Application
    Filed: April 24, 2020
    Publication date: October 29, 2020
    Inventors: Annahita KERAVALA, Diana CEPEDA, Mehdi GASMI
  • SEQUENTIAL INTRAVITREAL ADMINISTRATION OF AAV GENE THERAPY TO CONTRALATERAL EYES
    Publication number: 20200297869
    Abstract: Provided are methods of treating an ocular disease or disorder in a subject, comprising: administering a unit dose of a pharmaceutical composition to a first eye the subject via intravitreal (IVT) injection at a first time point, and administering a second unit dose of the pharmaceutical composition to a contralateral eye of the subject via IVT injection at a second time point.
    Type: Application
    Filed: March 4, 2020
    Publication date: September 24, 2020
    Inventors: Diana CEPEDA, Mehdi GASMI
  • ORGANOTYPIC PIG RETINA CULTURE SYSTEM
    Publication number: 20190154667
    Abstract: The present invention provides organotypic pig and non-human primate retina culture systems, and methods for evaluating or characterizing candidate therapeutic agents e.g. AAV-mediated gene vectors, using the same.
    Type: Application
    Filed: May 2, 2017
    Publication date: May 23, 2019
    Inventors: Annahita KERAVALA, Diana CEPEDA